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Cytoplasmic events depending on RNA-binding proteins con-
tribute to the fine-tuning of gene expression. Sterile  motif-con-
taining RNA-binding proteins constitute a novel family of post-
transcriptional regulators that recognize a specific RNA sequence
motif known as Smaug recognition element (SRE). The Drosophila
member of this family, dSmaug, triggers the translational repres-
sion and deadenylation of maternal mRNAs by independent mech-
anisms, and the yeast homologue Vts1 stimulates degradation of
SRE-containing messengers. Two homologous genes are present in
the mammalian genome. Here we showed that hSmaug 1, encoded
in human chromosome 14, represses the translation of reporter
transcripts carrying SRE motifs. When expressed in fibroblasts,
hSmaug 1 forms cytoplasmic granules that contain polyadenylated
mRNA and the RNA-binding proteins Staufen, TIAR, TIA-1, and
HuR. Smaug 1 foci are distinct from degradation foci. The murine
protein mSmaug 1 is expressed in the central nervous system and is
abundant in post-synaptic densities, a subcellular region where
translation is tightly regulated by synaptic stimulation. Biochemical
analysis indicated that mSmaug 1 is present in synaptoneurosomal
20 S particles. These results suggest a role for mammalian Smaug 1
in RNA granule formation and translation regulation in neurons.
Messenger RNA localization, translation activation, silencing, and
controlled degradation contribute to the fine-tuning of gene expression
in time and space. All these processes depend on several families of
RNA-binding proteins that are of comparable importance to transcrip-
tion factors in regulating gene expression (1). Sterile  motif (SAM)3-
containing RNAbinding domains define a novel family of RNA-binding
proteins that function as post-transcriptional regulators (2). They bind
to an RNA sequencemotif known as SRE (Smaug recognition element),
the Drosophila protein Smaug being the first member that was identi-
fied (2–5). Drosophila Smaug is involved in translational repression of
thematernal mRNA encoding nanos, a posterior determinant, and thus
plays a role in defining embryo polarity. Smaug recruits Cup, an eIF4E-
binding protein that prevents the association of eIF4E with eIF4G, thus
blocking initiation of the translation of SRE-containing messengers (6).
In addition, it has been reported recently that Drosophila Smaug medi-
ates degradation of maternal Hsp83 mRNAs by an independent mech-
anism that involves theCCR4deadenylase and does not requireCupnor
SRE motifs (7). The yeast homologue Vts1 stimulates degradation of
SRE-containing messengers by a similar mechanism (2).
Two Smaug homologous genes of unknown function are present in
the mammalian genome (2, 3). Here we show that Smaug 1, encoded in
human chromosome 14, represses translation of SRE-containing mes-
sengers in fibroblast cell lines. Both hSmaug 1 and Drosophila Smaug
form cytoplasmic granules when expressed in fibroblasts and colocalize
when cotransfected. Furthermore, hSmaug 1 foci contain polyadeny-
latedmRNAs, and their size and number depend on polysome integrity,
as described in the cases of stress granules (SG) and processing bodies
(PB) (8–10). We found that murine Smaug 1 is expressed in the brain
and is abundant in synaptoneurosomes, a subcellular region where
translation is tightly regulated by synaptic stimulation (reviewed in Refs.
11–18). Our results suggest a role for Smaug 1 in RNA granule forma-
tion and translation regulation of SRE-containing transcripts at post-
synaptic sites.
EXPERIMENTAL PROCEDURES
Plasmids and Library Screening—A pCDNA3.0 vector (Invitrogen)
encoding Drosophila Smaug was generated by subcloning the coding
region from a dSmaug cDNA kindly provided by Dr. C. Smibert (Uni-
versity of Toronto, Canada) using the primers 5-TAAGAACTATCC-
CGGTACCACAA-3 and 5-GATCAAATTTGCTCGAGTTCTCC-
3. Firefly luciferase reporters carrying three copies of either wild type or
mutated SRE were constructed by subcloning of the BamHI/HindIII
fragment of C145 and C146 plasmids, a generous gift of C. Smibert (19),
into a pcDNA3.0 vector. A pCDNA6.0 encoding murine Staufen 1
(GenBankTM accession number AF395842) (20) was used. The pre-
dicted coding region of hSmaug 1 from the AK034323 EST was sub-
cloned between HindIII and SacII sites in the pECFP-N1 vector (Clon-
tech) and KpnI and XhoI sites in the pcDNA6.0 vector (Invitrogen).
Screening of themouse brain, heart, kidney, testis, and embryo cDNA
libraries was performed at OriGene Technologies, Inc. (Rockville, MD)
using three pairs of primers: 5-GTGGAGTAGTGATTGCCGCTT-
G-3 and 5-CACTCGTTCCAGCCCTTAAACC-3; 5-CAGTCCA-
ACTCCCTCCCAACAG-3 and 5-AGTCTCTGCAACCCTGAAG-
ATGG-3; and 5-AGACTGTTGCACTGCTGTCG-3 and 5-TC-
CAATCGTGTTGATTGTGG-3.
Primary Antibody against Mammalian Smaug 1—Rabbit polyclonal
antisera were raised against the hSmaug 1 SAM domain, which was
prepared as similarly described for the Drosophila SAM domain (21).
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Supplemental Material can be found at: 
Briefly, XL1-Blue cells were transformedwith a pET22b expression vec-
tor (Novagen, San Diego) encoding the hSmaug 1-(306–371) fragment.
Bacteria were induced with 0.1 mM isopropyl 1-thio--D-galactopyr-
anoside for 12–16 h at 18 °C. After cell harvesting by centrifugation,
recombinant protein was purified using a nickel-nitrilotriacetic acid
column (Qiagen, Germantown, MD), recovered by elution in 300 mM
imidazole, and then dialyzed against PBS. Animals were bled after two
boosters.
Translation and Real Time PCR Assays—The following three plas-
mids were cotransfected into BHK-21 cells plated in 60-mm dishes (106
cells per dish) using Lipofectamine 2000 (Invitrogen) in Dulbecco’s
modified Eagle’s medium (Sigma) without serum and antibiotics: 1)
20–500 ng of pCDNA3.0 vector carrying the firefly-luciferase coding
region fused to a SRE tandem repeat, either wild type or mutated (2); 2)
10g of pECFP-hSmaug 1 or 6.7g of pECFP vector (Clontech); and 3)
50 ng of pRL-CMV (Promega,MadisonWI) encodingRenilla luciferase.
Twenty four hours after transfection, firefly and Renilla luciferase activ-
ities were quantified using the dual-luciferase reporter assay system
(Promega). Cell lysis was performed as indicated by the manufacturers,
andmeasurements were both taken immediately and after freeze-thaw-
ing, with no significant variations. Transfections were performed in
triplicate, and results were expressed as the average ratio of firefly to
Renilla luciferase activity.
Real time RT-PCR using SYBR Green (Molecular Probes, Eugene,
OR) was performed in triplicates of 1:10 serial dilutions of RNA using
the following primers: 5-tcgcggttgttacttgactg-3 and 5-cgatcttgttacaa-
cacccc-3 for firefly and 5-ggaaacggatgataactggtcc-3 and 5-aggc-
cgcgttaccatgta-3 for Renilla luciferase. Following Equation 2 in Ref. 22,
cycle threshold (CT) versus log [RNA dilution] was plotted. Only dilu-
tions where plot slopes ( 1  E (where E is the efficiency of target
amplification), according to Ref. 22, were close to 2 and similar for the
two templates (difference lower than 5%) were considered, indicating
similar amplification efficiencies (22). A linear regression was applied to
calculate the CT (firefly minus Renilla) and the corresponding S.D.
The ratio of firefly luciferase mRNA to Renilla luciferase mRNA was
calculated as (1  E)CT, where (1  E) was calculated from the slope,
and the standard deviation was calculated by error propagation.
Cell Transfection, Drug Treatment, and Immunofluorescence—HeLa,
BHK-21, and COS-7 cells were grown in Dulbecco’s modified Eagle’s
medium (Sigma) supplemented with 10% fetal bovine serum (Natocor,
Córdoba, Argentina), penicillin, and streptomycin (Sigma). Plasmid
transfection was performed in subconfluent cells plated onto poly-L-
lysine-coated coverslips using Lipofectamine 2000 (Invitrogen). Cells
were harvested or processed for immunofluorescence 8–16 h after
transfection. Fixation in 4% paraformaldehyde at 37 °C, 4% sucrose in
PBS was performed with or without prior extraction of living cells in
CSKbuffer (CSKB: 25mMKCl, 1mMHEPES, pH6.8, 1mMEGTA, 5mM
MgCl2) containing 0.25 M sucrose and Triton X-100 0.1% for 1 min.
After fixation, cells were permeabilized in 0.1%TritonX-100 in PBS and
blocked in 2% bovine serum albumin. Primary antibodies were diluted
as follows: anti-mammalian Smaug 1, 1:500 to 1:1000, and RLS1, 1:500;
anti-PABP rabbit polyclonal antibody (kindly provided by Dr. Evita
Mohr, University of Hamburg, Germany), 1:500; anti-TIA-1 goat poly-
clonal antibody 1:100 (Santa Cruz Biotechnology, Santa Cruz, CA).
Monoclonal antibodies and suppliers are as follows: anti-TIAR, SMN
(BD Biosciences); anti-HuR and anti-GW182 (Cytostore, Calgary,
Alberta, Canada), anti-hPABP (ImmuQuest, Cleveland; UK), 1:100, and
anti-V5 (Invitrogen), 1:500. Secondary antibodies were fromMolecular
Probes or Jackson ImmunoResearch (West Grove, PA). Cells were
mounted in Mowiol 4-88 (Calbiochem, EMD Biosciences, Inc). Images
were acquired using an LSM-5 PASCAL confocal microscope (Carl
Zeiss, Oberkochen, Germany). Proper equipment adjustment was
ensured using 1-m FocalCheck fluorescent microspheres (Molecular
Probes).
Cycloheximide and puromycin (Sigma) were added to conditioned
media from stock aqueous solutions. Treatment with 50 ng/ml lepto-
mycin B (Sigma) was performed in conditioned media for 2 h.
Biochemical Fractionation, Sedimentation Velocity Centrifugation,
and Western Blotting—Brains from 6-week-old mice were homoge-
nized in 0.8 M sucrose, in CSKB containing the following protease inhib-
itors: 4-(2-aminoethyl)benzenesulfonyl fluoride, pepstatin A, E-64,
bestatin, leupeptin, and aprotinin (all from Sigma). Synaptoneuro-
somes, post-synaptic densities, and a membrane fraction were isolated
as described previously (23). For sedimentation velocity centrifugation,
brain post-synaptic densities or post-nuclear extracts from cultured
cells were prepared in CSKB containing 1% Triton X-100, 0.25 M
sucrose. Samples of 0.5–1 mg of protein (determined by the bicincho-
ninic acid protein kit assay; Sigma) were loaded onto continuous 13-ml
sucrose gradients (20–60, 15–45, or 10–30% w/v in CSKB) and centri-
fuged at 220,000  g for either 2 or 4 h. When required, 1 unit of
-galactosidase was added as a 20 S marker. The polysomal profile was
monitored by absorbance at 260 nm and -galactosidase activity by
colorimetric o-nitrophenyl -D-galactopyranoside reaction. Protein
from 1-ml fractions was precipitated in chloroform/methanol (1:2)
using 20g of lysozyme as carrier and analyzed byWestern blot. Briefly,
protein was resuspended in Laemmli sample buffer, separated by SDS-
PAGE, and electrotransferred to Immobilon-P polyvinylidene difluo-
ride membranes (Millipore, Bedford, MA). The following primary anti-
bodies were used: anti-mammalian Smaug 1, diluted 1:10,000 to
1:20,000; anti-Staufen 1RLS1, 1:5000 (20); rabbit anti-S6 (Cell Signaling,
Beverly,MA), 1:1000; and anti-Drosophila Smaug (generous gift fromC.
Smibert,), 1:10,000. Detection of peroxidase-conjugated anti-V5 anti-
body (Invitrogen) and peroxidase-coupled secondary antibodies
(Sigma) was performed by chemiluminescence using the LumiGlo sys-
tem (Cell Signaling).
RESULTS
Mammalian Smaug 1 Represses Translation of SRE-containing
mRNAs—The two genes homologous to Drosophila Smaug present in
mammalian genomes were named as Smaug 1, located in human and
mouse chromosome 14, and Smaug 2, located in human chromosome
19 and mouse chromosome 7 (Fig. 1A). We performed a screening of
mouse brain, liver, testis, and whole embryo libraries and found two
mSmaug 1 transcripts. The most frequent of them corresponds to a
previously reported EST (GenBankTM accession number AK034323),
and the second most frequent corresponds to a novel late embryonic
5-untranslated region splicing variant (Fig. 1B). No splicing variants
involving the coding region were found in our screening nor in the
available data bases, including human and mouse sequences. We con-
firmed the presence ofmSmaug 1 transcripts in brain, kidney, heart, and
liver by RT-PCR analysis (Fig. 1C).
We sought to investigate the effect of mammalian Smaug 1 on trans-
lation and stability of SRE-containing messengers. Although the direct
interaction of hSmaug 1 with SRE-containing messengers was not
addressed in this study nor in previous reports, it has been shown pre-
viously that SAMdomains of vertebrate Smaug homologues specifically
recognize SREs (2, 5). BHK cells were cotransfected with plasmids
encoding an enhanced cyan fluorescence protein (ECFP) or a hSmaug
1-ECFP chimera together with firefly luciferase-translational reporters
bearing either wild type or mutated SREs in a trimeric tandem array
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(3xSRE and 3xSRE, respectively) (19). A plasmid encoding Renilla
luciferase to normalize for transfection efficiency was cotransfected.
We found that in the presence of hSmaug 1-ECFP the firefly luciferase
activity yielded from 3xSRE-containing transcripts was reduced to
43% relative to the ECFP control. In contrast, firefly luciferase activity
yielded from3xSRE reporters was the same in the presence of hSmaug
1-ECFP or ECFP (Fig. 2A). When extracts of cells expressing firefly
luciferase were preincubated with extracts of cells expressing hSmaug
1-ECFP, no effects on luciferase activity levels were observed (not
shown), further indicating that luciferase reporters are notmodulated at
the protein level by hSmaug 1.
Simultaneously, firefly and Renilla luciferase mRNA levels were
determined by real time PCR. The abundance of the firefly reporters
relative to the coexpressed control Renilla mRNA was not affected by
the expression of hSmaug 1 (Fig. 2B). As expected, the translational
repression was proportional to the relative amounts of hSmaug 1
(Fig. 2C).
These results indicate that human Smaug 1 represses translation of
SRE-containing messengers without affecting their stability. The possi-
bility of an effect on mRNA decay or deadenylation by recruitment of
the CCR4 deadenylase, as is the case of theDrosophilamolecule (7), in a
different molecular or cell context was not analyzed, and thus this
remains open.
Murine Smaug 1 Is Present in Brain Synaptoneurosomes and Forms
Small Particles—An antibody raised in our laboratory against the native
SAM domain of hSmaug 1 specifically recognized the human protein in
Western blot assays of BHK cells expressing hSmaug 1-V5. Expression
of endogenous Smaug 1 was not detected in BHK or other fibroblasts
cell lines (Fig. 3A and data not shown).
Next, we evaluated the expression of Smaug 1 in the brain, as trans-
lational regulation is frequent in neurons (11, 13–15, 17, 24). A protein
band of 70 kDa was observed in blots of mouse and rat brain extracts,
in accordance with the predicted molecular weight of mSmaug 1 (Fig.
3B). We then examined the distribution of mSmaug 1 in brain subcel-
lular fractions. Murine Smaug 1 was enriched in synaptoneurosomes
(Fig. 3C), and a further purification indicated that mSmaug 1 concen-
FIGURE 1. Drosophila and mammalian Smaug proteins. A, single smaug gene with no
alternative splicing is present in Drosophila. SSR1 and SSR2 indicate the Smaug similarity
regions described in Ref. 3. The RNA binding domain includes the SAM domain. Two
Smaug homologous proteins are present in human and mouse. The percentage of iden-
tity with the corresponding Drosophila domains is indicated. In all cases, identity among
mammalian SSR1, SSR2, or SAM domains is higher than 90%. B, the mouse smaug 1 gene
has two alternative splicing variants encoding a single Smaug 1 molecule. Initiation and
stop codons are indicated with arrowheads. A predicted nuclear localization signal
(LTPIKAYSSP) is indicated by an open arrowhead. C, expression of smaug 1 was evaluated
by library screening and RT-PCR experiments. NA indicates not assessed.
FIGURE 2. Mammalian Smaug 1 represses translation of SRE-containing mRNAs. A,
BHK cells were transfected with hSmaug 1-ECFP or ECFP cDNAs and firefly luciferase
reporters in a 40:1 molar ratio. Levels of firefly luciferase (F) relative to that of cotrans-
fected Renilla luciferase (R) are plotted. B, mRNA levels were evaluated by real time PCR in
the same experiment as in A. Calculations were performed as indicated under “Experi-
mental Procedures,” and values in the presence of enhanced green fluorescent protein
(EGFP) were taken as 100%. C, translation inhibition was evaluated in independent
experiments where the molar ratio of ECFP reporters to firefly luciferase reporters was
10:1, 20:1, or 40:1. Translation in the presence of hSmaug 1-ECFP (hSmg1) relative to that
in the presence of ECFP is indicated. Translation of 3xSRE transcripts was not affected,
and SRE containing mRNA levels remained constant (data not shown).
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trates in post-synaptic densities, a fraction from synatoneurosomes
almost membrane-free and enriched in cortical cytoskeleton and syn-
apse-associated elements, such as localized mRNAs and polyribosomes
and the marker protein PSD-95 (11, 13, 16). In contrast, mSmaug 1 was
FIGURE 3. Smaug 1 is present in brain synaptoneurosomes as 20 S particles. A, poly-
clonal antibody against the SAM domain of the human Smaug 1 molecule (hSmg1) was
used in Western blot assays. Extracts from BHK cells transfected with a hSmaug 1 con-
struct fused to V5 () or nontransfected () were analyzed. Equivalent amounts of pro-
tein extracts were loaded, and -actin was detected as a loading control. Dilutions of the
primary antibody are indicated. No signal was observed with a preimmune serum. B,
Western blot analysis of adult mouse (Mo) and P0 rat brain. C, Western blot analysis (left)
of total brain (B), crude synaptoneurosomes (S), membrane from synaptoneurosomes
(M), postsynaptic densities (P), and rat oligodendrocyte primary culture extract (O). Right,
Coomassie Brilliant Blue staining of the same filter. Twenty g of protein were loaded in
total brain, crude synaptoneurosomes, and rat oligodendrocyte primary culture extract,
and 5 g in membrane from synaptoneurosomes and postsynaptic densities. D, PSD
extract was analyzed in sedimentation sucrose gradients (20 – 60%, top panel or 10 –30%,
bottom panel). Individual fractions were collected, and the presence of mSmaug 1,
Staufen 1 (Stau1), and the small ribosomal marker S6 were simultaneously detected by
Western blot. -galactosidase was included in the bottom gradient as a 20 S marker.
FIGURE 4. Drosophila and mammalian Smaug 1 form cytoplasmic granules in fibro-
blasts. A, left, cytoplasmic granules containing hSmaug 1 were observed after 8 h of
expression of hSmaug 1-ECFP in COS-7 cells. Right, immunofluorescence (IF) with the
polyclonal antibody raised against the hSmaug 1 (hSmg1) SAM domain. B, hSmaug 1-V5
cytoplasmic foci and a homogeneous nuclear staining are observed after a Triton X-100
(TX100) extraction of living cells. C, subcellular distribution hSmaug 1-V5 after exposure
to leptomycin B (LMB). D, Drosophila Smaug (dSmg) forms cytoplasmic granules in COS-7
cells, and complete overlapping was observed when coexpressed with hSmaug 1-ECFP
(E). F, a sedimentation velocity gradient was performed after coexpression of hSmaug
1-V5 and Drosophila Smaug (top) or hSmaug 1-V5 and murine Staufen 1-V5 in BHK cells
(bottom).
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not detected in the synatoneurosomes membrane fraction (Fig. 3C). It
also seems to be absent frommyelin, as an oligodendrocyte extract gave
no signal (Fig. 3C). Taken together, these results suggest that mSmaug 1
is localized in neuronal structures associated with dendritic synapses.
Next, we investigated the interaction of mSmaug 1 with the synapto-
neurosomal translational apparatus by sedimentation velocity analysis.
After centrifugation through a sucrose gradient, mSmaug 1migrated as
a 20 S particle and appeared not to be associated with polyribosomes or
with ribosomal subunits (Fig. 3D). As expected, the double-stranded
RNA-binding protein Staufen 1 was detected in polysomes and in a
faster sedimenting fraction (Fig. 3D), as described previously (16, 20,
25–28). These results are compatible with a role of mSmaug 1 in inhi-
bition of translation initiation in neurons.
Smaug Forms Cytosolic Granules That Contain Polyadenylated
RNA—To analyze further translational repression by mammalian
Smaug 1, tagged hSmaug 1 molecules were transiently transfected in
fibroblast cell lines, and their subcellular distribution was then ana-
lyzed by immunofluorescence and sedimentation velocity gradients.
We found that a large proportion of Smaug 1 concentrated in cyto-
plasmic granules no larger than 0.5–2 m (Fig. 4A). These granules
were observed in COS-7, BHK, and HeLa cells transfected with two
different human Smaug 1 chimeras, fused to ECFP or to the small tag
His6-V5 (Fig. 4 and data not shown). Most cells (66–85%) showed the
representative phenotype depicted in Fig. 4A, granule size, and number
as being roughly proportional to expression levels (TABLE ONE). As
expected, transfected ECFP presented no granules (data not shown).
Human Smaug 1 granules were distributed throughout the cytoplasm
and were also observed after Triton X-100 extraction of living cells (Fig.
4B), whereas the nonpunctate hSmaug 1 signal was no longer present
(see also TABLEONE). Treatment with the CRM1-inhibitory drug lep-
tomycin B strikingly increased the otherwise minor nuclear hSmaug 1
staining (Fig. 4, B and C), suggesting that this protein is shuttling
between the nucleus and the cytoplasm. Smaug 1 foci were extremely
infrequent in the nuclear compartment; the protein showed a homoge-
neous distribution throughout the nucleoplasm (Fig. 4C).
Remarkably, Drosophila Smaug also formed cytoplasmic granules
when expressed in fibroblast cell lines (Fig. 4D).Moreover, theDrosoph-
ila protein colocalized with mammalian Smaug 1 when coexpressed
(Fig. 4E), further suggesting a functional similarity between the fly and
the mammalian homologues.
We then performed a subcellular fractionation of BHK cells express-
ing hSmaug 1-V5. Transfected hSmaug 1 was quantitatively recovered
in the cytosolic fraction. When post-nuclear extracts were analyzed by
sedimentation velocity centrifugation, hSmaug 1 migrated close to the
20 S marker (Fig. 4F), similar to the synaptoneurosome-associated
mSmaug 1 (Fig. 3D).We simultaneously analyzed the distribution of the
Drosophila protein coexpressed in the same conditions. Most interest-
ingly, fly Smaug also migrates as a small ribonucleoparticle or free pro-
tein (Fig. 4F). Finally, for comparison, a construct encoding Staufen
1-V5 was cotransfected with hSmaug 1-V5 and analyzed simulta-
neously. Similarly to the endogenous Staufen 1 (Fig. 3D), Staufen 1-V5
comigrated with polysomes (Fig. 4F), indicating that overexpression is
not perturbing the subcellular distribution of the transfected proteins.
Furthermore, the absence of the transfected dSmaug and hSmaug 1 in
fast sedimentation fractions, together with the plasticity of hSmaug 1
foci (see below), indicate that Smaug foci were not aggregates of mis-
folded proteins.
Given that hSmaug 1 repressed the translation of SRE-containing
transcripts (Fig. 2), we investigated the presence of messenger RNA in
the hSmaug 1 foci. Detection of the general PABP in these structures
indicated that Smaug granules likely contain polyadenylated RNA.
Remarkably, PABP became granular in all cells bearing hSmaug 1 foci,
regardless of their size (Fig. 5, A, B, and D). This was observed in both
BHK and COS-7 cells at different expression times and by using poly-
clonal or monoclonal anti-PABP antibodies (Fig. 5, A and B). PABP
presented a uniform cytoplasmic staining in nontransfected cells (Fig.
5A), and expression of ECFP had no effect on PABP distribution (Fig.
5C). PABP was retained in hSmaug 1 foci after Triton X-100 extraction
(Fig. 5D), and strict colocalizationwas confirmed in all foci in 94% of the
cells, regardless of size and subcellular localization (Fig. 5D, see also
TABLE ONE
Presence of TIA-1, TIAR, and PABP in hSmaug 1 foci
The frequency of hSmaug 1 foci and the presence of marker proteins in those foci were analyzed in independent transient-transfection experiments by
immunostaining and confocal microscopy. Determinations were performed after 16 h of expression, unless indicated otherwise. N indicates number of trans-
fected cells analyzed. Cells with more than four hSmaug1 granules larger than 0.5 m were considered as containing foci. The percentage relative to total
transfected cells is indicated. The percentage of cells showing colocalization with the different markers was relative to the number of granule-containing cells.
Cells were scored as positive for colocalization whenmore than 60% of their hSmaug1 foci contained the analyzedmarker. Cells positive for PABP colocalization
always showed more than 95% of double-stained foci. No differences in colocalization frequency of the distinct markers were observed between high expressing
and low expressing cells (not shown). ND indicates not determined.
Construction Cell line N Foci PABP TIAR TIA-1
% % % %
hSmg1-ECFP BHK-21a 400 66 ND ND ND
58 85 100 ND ND
73 76 ND 63 69
167 83 ND ND 79
BHK-21 141 83 ND 65 ND
114 70 98 52 ND
COS-7 112 83 94 64 ND
hSmg1-V5 BHK-21 138 80 93 ND 66
123 81 ND 66 ND
COS-7 99 83 ND 68 ND
hSmg1-ECFP (after Triton X-100) BHK-21 90 100b 84 77 ND
COS-7 97 100b 92 73 ND
a Determinations were performed after 8 h of expression.
b Nongranular hSmaug1 signal was washed out after Triton extraction of living cells, and therefore the remaining signal was granular in 100% of the cases.
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TABLE ONE). The distribution of SMN and Staufen 1, two RNA-bind-
ing proteins that form granules in neurons (26, 29), was also compared.
Human Smaug 1 and the endogenous SMN localized in distinct cyto-
plasmic foci, whereas Staufen 1 was frequently detected in hSmaug 1
granules (Fig. 5E). Similar to PABP, Staufen 1 distribution was not
affected by ECFP expression, indicating that PABP and Staufen 1 were
selectively recruited to hSmaug 1 foci.
Cytoplasmic RNA granules are compatible with degradation foci,
which are ubiquitous structures containing proteins involved in RNA
decay (30). Thus, we investigated whether GW182, an RNA-binding
protein marker of degradation foci (31, 32), was present in hSmaug 1
granules. Complete reciprocal exclusion of GW182 and hSmaug 1 was
observed in the foci in two independent experiments in HeLa cells. The
overall distribution of GW182 remained unchanged in hSmaug 1-ex-
pressing cells (Fig. 5F).
We concluded that in fibroblast cell lines bothmammalian hSmaug 1
and fly Smaug form 20 S particles that do not contain ribosomal sub-
units and that cluster into larger granules containing polyadenylated
RNA. In addition, cytoplasmic hSmaug 1 granules do not overlap with
the previously described degradation foci or SMN granules.
FIGURE 5. Smaug 1 granules contain PABP and are distinct from SMN granules and degradation foci. Staining for PABP (A–D), SMN, and Staufen 1 (E) or GW182 (F) was performed
after transfection of hSmaug 1 constructs (hSmg1) or ECFP in COS-7 cells after 16 h of expression (A and D); BHK cells after 8 h of expression (B); BHK cells after 16 h of expression (C
and E) or in HeLa cells after 16 h of expression (F). Polyclonal anti-PABP was used in A and D, and monoclonal anti-PABP was used in B and C. Human Smaug 1 granules contain PABP
(A and B), and PABP is retained in the foci after Triton X-100 extraction of living cells (D). E, Staufen 1 and SMN were detected simultaneously. The presence of Staufen 1 in a number
of hSmaug 1-ECFP granules is indicated by arrows. F, P bodies were identified by staining for GW182.
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Smaug 1 Foci Are in Equilibrium with Polysomes and Contain SG
Markers—As our results indicate that Smaug 1 granules may contain
polyadenylated RNA in a silent state, and cytoplasmic granules contain-
ing silenced mRNA can be in dynamic equilibrium with translating
polysomes (8, 16, 30, 33), we sought to investigate the effect of drugs that
affect polysome stability on hSmaug 1 foci.We found that after a strong
treatment with the polysome-stabilizing drug cycloheximide, hSmaug 1
granules disappeared almost completely (Fig. 6). The effect was time-
and dose-dependent; both granule size and number were always smaller
after cycloheximide exposure (Fig. 6, B and C, and data not shown).
Remarkably, puromycin, which inhibits translation by disrupting poly-
somes, provoked the opposite effect; more hSmaug 1 granules were
observed, and these granules were significantly larger (Fig. 6, B and C).
Inhibition of protein synthesis by either cycloheximide or puromycin
did not affect hSmaug 1 levels (Fig. 6A). The disruption of hSmaug 1
granules by cycloheximide treatment together with the granule-en-
hancement effect elicited by puromycin indicate that hSmaug 1 foci are
dynamic and that their formation and dissolution are linked to poly-
some integrity.
Smaug 1 foci plasticity is reminiscent to that of SGs that are induced
during cell stress and contain transiently silenced mRNAs (8). Remark-
ably, we found that Staufen 1, which was recently reported as an SG
component (20), was recruited into hSmaug 1 foci (Fig. 5E). Therefore,
we investigated the presence of SG markers in hSmaug 1 foci. We
focused on TIAR and TIA-1, two nucleus-cytoplasm shuttling proteins
that are present in SG (8, 33, 34). Most hSmaug 1 foci were observed to
contain TIAR and TIA-1 in independent transfection experiments per-
formed in BHKorCOS-7 cells (Figs. 7 and 8). ColocalizationwithTIA-1
and TIAR was observed in both the small foci (Fig. 7A) as well as in the
large foci present at higher expression levels (Fig. 7B) and resisted the
extraction with nonionic detergents (Fig. 7C and TABLE ONE). As
reported previously (35), the presence of cytoplasmic granules contain-
ing TIAR/TIA-1 was observed in 15–20% of ECFP-transfected cells and
was less than 5% in nontransfected cells (data not shown), indicating a
minor cellular stress likely due to plasmid transfection and general pro-
tein overexpression. HuR, another nuclear protein present in stress
granules (34), was also frequently detected in the hSmaug 1 foci (Fig. 8).
In both extracted and nonextracted cells, we observed that about 25%
of cells expressing hSmaug 1-ECFP or hSmaug 1-V5 lacked TIAR and
TIA in some foci (Fig. 7C andTABLEONE). A similar phenomenonwas
observed previously for G3BP-induced stress granules (35). We found
that these two SG-marker proteins were simultaneously present or
absent from hSmaug 1 foci. More importantly, the TIAR/TIA-1-nega-
tive foci always contained PABP (Fig. 7, C and D), thus suggesting that
the presence of polyadenylated transcripts was independent of the
recruitment of TIAR/TIA-1.
The two previously described foci, SG and PB,were recently shown to
interact physically, displaying encapsulation of PB by SG, juxtaposition,
or fusion (30, 36, 37). The spatial relationship between hSmaug 1 foci
and SG markers was analyzed by confocal slicing (Fig. 8). The intensity
profile of the hSmaug 1 signal along a line crossing several foci strictly
correlated with that of TIAR (Fig. 8A) andHuR (Fig. 8B), indicating that
these molecules overlapped spatially in the foci. In contrast, the PB
marker GW182 did not colocalize with hSmaug 1, although they were
frequently observed in adjacent foci (Fig. 5F and data not shown).
Altogether, these observations indicate the following: transiently
transfected hSmaug 1 forms foci distinct from processing bodies; are in
equilibrium with translating polysomes; always contain polyadenylated
RNA, and frequently contain stress-granule markers.
DISCUSSION
We have characterized Smaug 1, a mammalian homologue of Dro-
sophila Smaug, an RNA-binding protein defining a novel family of post-
transcriptional regulators involved in mRNA silencing and deadenyla-
tion (2–4, 7). We found that hSmaug 1 represses the translation of
SRE-containingmessengers and no effect of human Smaug 1 onmRNA
stability was observed in fibroblast cell lines. It is still possible that
hSmaug 1 or other mammalian orthologues may have a role in RNA
degradation in a different cell context. We found that in the absence of
hSmaug 1 constructs, the abundance of SRE-containing transcripts was
lower than that of transcripts bearingmutated SRE, and simultaneously,
the translation efficiency was stimulated by the presence of SRE motifs
(data not shown). This likely suggests the presence of unknown endog-
enous factors regulating the activation or stability of SRE-containing
transcripts that was not analyzed further.
Themechanism involved inmRNA repression bymammalian Smaug
1 has not been addressed in this study, but it is likely to be similar to the
one reported for Drosophila Smaug; dSmaug binds Cup, which in turn
FIGURE 6. Smaug 1 granules are dynamic structures in equilibrium with translating
polysomes. BHK cells transiently expressing hSmaug 1-V5 for 16 h or hSmaug 1-ECFP for
8 h were exposed to 0.25 mg/ml cycloheximide (CHX) or 0.25 mg/ml puromycin (PUR). A,
after 2 h of treatment 20 and 5 g of total protein were analyzed by Western blot with
anti-V5 and -actin antibodies, showing no differences in the levels of hSmaug 1-V5 (C
indicates control). B, representative cells after 2 h of treatment are shown. C, percentages
of hSmaug 1-ECFP-transfected cells with more than four granules larger than 0.5 m
after 2 or 3 h of treatment are indicated. Similar values were obtained with the hSmaug
1-V5 construct.
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binds to eIF4E, thus preventing eIF4G recruitment (6). As a conse-
quence, translation initiation is blocked, and ribosome subunits cannot
be recruited. A human Cup homologous protein has been identified,
and similar toDrosophilaCup, this ubiquitousmolecule, known as 4ET,
inhibits the interaction of eIF4E with eIF4G (39). Our observation that
Drosophila and mammalian Smaug form 20 S particles that do not
include 40 S ribosomal subunits is compatible with a role for these mol-
ecules in translation initiation blockage. These 20 S particles appear to
build up large aggregates inside cells, which can be visualized as gran-
ules. The formation of hSmaug 1 cytoplasmic granules was observed in
several different cell lines, and in all cases, they contained PABP, sug-
gesting the presence of polyadenylated SRE-containingmessengers.We
FIGURE 7. Smaug 1 granules contain SG mark-
ers. Human Smaug 1 (hSmg1) constructs were
expressed in BHK cells (A–C) and COS-7 cells (D).
Immunostaining for the indicated proteins was
performed in nonextracted cells (A, B, and D) or
after Triton extraction of living cells (C) after 16 h of
expression. TIAR and TIA-1 were simultaneously
detected in hSmaug 1 foci, regardless of expres-
sion levels and granule size (A and B). Foci negative
and positive for TIA-1 and TIAR coexist inside cells,
and all foci contain PABP (C and D).
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found that hSmaug 1 foci enlarge when polysomes are disrupted, and
conversely, they disassemble in the presence of the polysome-stabilizing
drug cycloheximide, as reported for stress granules and more recently
for processing bodies (8, 16, 30, 33, 37).
In addition to PABP, hSmaug 1 foci frequently contained TIAR,
TIA-1, and HuR, three RNA-binding proteins that are normally con-
centrated in the nucleus and that are recruited to cytoplasmic stress
granules (8–10, 34) and Staufen 1, a ubiquitous double-stranded RNA-
binding protein recently described to be an SG component (20).
The finding that both fly and mammalian Smaug induce the forma-
tion of cytoplasmic granules containing stress granule markers in the
absence of cell stressors was unexpected. Nevertheless, this observation
is compatible with the fact that dSmaug and hSmaug 1 are translational
repressors, given that stress granules are formed when translation initi-
ation is impaired by cellular stress, expression of a phosphomimetic
mutant of eIF2, or translation inhibitory drugs (8, 9, 20, 33, 38, 40).
Furthermore, stalled translation initiation complexes have been sug-
gested to function as nucleation centers for SG aggregation (10).
By extending our observations on Smaug, we speculate that SG-re-
lated structures would assemble onto core complexes of mRNA and
proteins that block translation initiation. Relevantly, the translation
inhibitor CPEB was recently shown to form similar granules in the
absence of stress when overexpressed (36). Despite the presence of SG
markers in hSmaug 1 cytoplasmic foci observed under normal condi-
tions, these foci do not necessarily represent structures identical to the
stress granules observed upon induction of cellular stress, as SG forma-
tion is a consequence of the activation of a complex signal transduction
pathway not expected to be activated by Smaug expression.
As an alternative to the de novo formation of granules induced by
Smaug, we should consider the possibility of Smaug being recruited to
pre-existing cytoplasmic structures, like the PB that are present in all
cell type (30, 31, 32, 36, 37). Relevantly, fly Smaug and the yeast homo-
logue Vts1 trigger mRNA deadenylation by direct interaction with
CCR4 (2, 7) that localize at degradation foci in mammalian cells (30). In
addition, 4ET, a mammalian homologue of Cup, a molecular partner of
Drosophila Smaug, was recently reported to be present in processing
bodies (37, 41). We found that Smaug 1 foci contain PABP in BHK,
COS-7, and HeLa cells, likely indicating the presence of polyadenylated
mRNA, which is normally excluded from degradation foci (30, 37) but
that can be detected when mRNA degradation is impaired (30). Never-
theless, we found that the presence of hSmaug 1 and the degradation
foci marker GW182 in cytoplasmic granules are mutually exclusive in
HeLa cells.
Thus, Smaug 1 granules containing silencedmRNAsmay be expected
to be present at the postsynapse, where this protein accumulates. The
formation of hSmaug 1 cytoplasmic granules in fibroblasts indicates
that neuron-specific factors are not required, thus underscoring the
capacity of Smaug as an RNA granule-forming protein and suggesting
the presence of similar structures in neurons. Relevantly, Drosophila
Smaug also concentrates in granules, likely the polar granules, at the
posterior of the embryo and is present in the fly central nervous system
during embryogenesis (3, 4). Thus, it seems possible that Smaug 1 mol-
ecules located at post-synaptic sites specifically sequester SRE-contain-
ing transcripts in granules, where translation is suppressed. More
importantly, a growing number of RNA-binding proteins thought to be
involved in the local regulation of gene expression are present in den-
drites and post-synaptic sites forming granules (11, 26, 29, 42–45). Rel-
evantly, some of them, namely Staufen, SMN, fragile X mental retarda-
tion protein, and ELAV family members, are also found, under certain
conditions, in larger accretions eventually identified as stress granules in
a number of cases (20, 46–48).
Mechanisms for translational regulation contributing to synapse for-
FIGURE 8. Colocalization of TIAR and HuR in hSmaug 1 foci. BHK cells expressing
hSmaug 1-ECFP were immunostained for TIAR (A) or HuR (B), and confocal optical slicing
of representative hSmaug 1 (hSmg1) foci was performed. Intensity profiles for marker
molecules on each Z plane were recorded using a line scan. Bottom panels, representa-
tive analysis of intensity peaks showing correlation of SG marker proteins and hSmaug 1
(Smg) signal along the lines in each slice of the Z stack.
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mation and plasticity include CPEB-mediated poly(A) elongation (15),
use of an internal ribosome entry site (49, 50), and translation regulation
by fragile X mental retardation protein and BC1 (24), among others. In
addition, availability and activity of general factors for protein synthesis
are also regulated at the synapse (11, 14, 17, 18). Our results suggest the
SRE-Smaug system as a novel additional mechanism for local transla-
tional control at the synapse. A survey of neuronal messengers contain-
ing SREs in data bases yielded a reduced number of mRNAs encoding
distinct functions.4 Some of them are known to be localized at the den-
dritic compartment, and thus, the possibility exists that Smaug contrib-
utes to the regulation of these transcripts. This hypothesis and whether
Smaug is controlled by synaptic activity have yet to be confirmed.
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